This study assessed the relationships between rivaroxaban-specific anti-factor Xa activity (AXA) and unfractionated heparin (UFH)-specific AXA and determined the cutoff level for UFH-specific AXA in critical situations for patients undergoing rivaroxaban therapy. Methods Thirty-eight blood samples were ...
The anti–factor Xa assay is designed to measure plasma heparin (unfractionated heparin [UH] and low molecular weight heparin [LMWH]) levels and to monitor anticoagulant therapy. Therapeutic ranges of heparin are as follows: LMWH: 0.
精准监测之Anti-Xa 精准监测之Anti-Xa 抗Xa活性测定，可针对临床上广泛用于预防和治疗血栓性疾病的抗凝血药物—普通肝素和低分子肝素的药效进行监测，较传统的实验室监测方法APTT，抗Xa活性测定方法更为特异，检测结果稳定，可以更真实地体现病人体内的抗凝效果。本文参考相关国内外文献及临床指南/共识，对肝素监测的两...
This study assessed the relationships between rivaroxaban-specific anti-factor Xa activity (AXA) and unfractionated heparin (UFH)-specific AXA and determined the cutoff level for UFH-specific AXA in critical situations for patients undergoing rivaroxaban therapy. Methods Thirty-eight blood samples were ...
INNOVANCE Anti-Xa assaySimplify your anticoagulant testing The INNOVANCE®Anti-Xa assay1is an automated chromogenic assay for the quantitative determination of the activity of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) as well as rivaroxaban, apixaban and edoxaban concentrations...
Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy. Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy.Unfractionated heparin (UFH) has ... Jung-Hyun,Byun,In-...
Background: Unfractionated heparin has been traditionally used for anticoagulation during hemodialysis (HD), but more recently low-molecular-weight heparin (LMWH) is being used as an alternative. Anti-Xa activity can be measured as a surrogate of LMWH efficacy. We present 52 patients treated with ...
Low Molecular Weight Heparins, Antiactor Xa and Anti-Factor IIa Assays for Unfractionated Heparin ...
Safety and Effectiveness of an Anti-Xa-based Unfractionated Heparin Protocol for Impella Percutaneous Ventricular Assist Devices Results: Anti-Xa values were in therapeutic range 46% of the time while on support (interquartile range 16.6%-75%), with a median IV UFH dose of ... SE Berman,L ...
Bara L,Leizorovicz A,Picolet H, et al.Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group. Thrombosis Research . 1992...